Bringing the fundamentals into focus…
Back to Ligand Pharmaceuticals Incorporated
How Ligand Pharmaceuticals Incorporated stacks up
LGND · against 213 other Healthcare companies of similar size
Overall
78/ 100
Near the top of its peers.
Ranked #6 of 214 · scores higher than 97% of peers
Bars: peers in each 10-point band of the overall score26 peers with an overall score of 70–79, including LGND · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around LGND| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 3 | 921.9B INR (≈$11.1B) | 82 | 84 | 80 | 94 | 0 / 2 | |
| 4 | 936.1B JPY (≈$6.4B) | 80 | 65 | 86 | 94 | 0 / 2 | |
| 5 | 40.3B SEK (≈$4.0B) | 79 | 43 | 84 | 97 | 0 / 2 | |
| 6 | 10.7B USD | 78 | 77 | 85 | 84 | 0 / 2 | |
| 6 | 9.0B USD | 78 | 50 | 80 | 94 | 0 / 2 | |
| 6 | 6.3B USD | 78 | 50 | 90 | 86 | 0 / 2 | |
| 9 | 679.6B INR (≈$8.2B) | 77 | 65 | 75 | 91 | 0 / 2 | |
| 10 | 80.2B CNY (≈$11.2B) | 76 | 95 | 52 | 93 | 1 / 2 | |
| 10 | 14.87T KRW (≈$10.7B) | 76 | 37 | 97 | 94 | 0 / 2 | |
| 12 | 22.7B CNY (≈$3.2B) | 75 | 76 | 47 | 91 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score